SRC Inhibition Is Still a Relevant Target in Pancreatic Cancer

Oncologist - United States
doi 10.1634/theoncologist.2013-0410
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

“Gastric Cytoprotection” Is Still Relevant

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2014English

P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2006English

A Multistep High-Content Screening Approach to Identify Novel Functionally Relevant Target Genes in Pancreatic Cancer

PLoS ONE
Multidisciplinary
2015English

Mesothelin Is a Malignant Factor and Therapeutic Vaccine Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2007English

McL-1 Is a Relevant Molecular Target for Antisense Oligonucleotide Strategies in Gastric Cancer Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

PHA-739358, a Potent Inhibitor of Aurora Kinases With a Selective Target Inhibition Profile Relevant to Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

Japan as an Economic Model: Is It Still Relevant?

Jurnal Asia Pacific Studies
2018English

Amino Acid Transporter SLC6A14 Is a Novel and Effective Drug Target for Pancreatic Cancer

British Journal of Pharmacology
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy